Adalimumab is an anti-inflammatory medication. It binds to tumor necrosis factor-alpha (TNFa), reducing inflammation in autoimmune diseases.

---

Adalimumab is an anti-inflammatory medication. It binds to tumor necrosis factor-alpha (TNFα). Binding of TNFα to the specific receptors leads to the inflammatory response in autoimmune diseases. Treatment with adalimumab reduces this inflammatory response.

---

Size: 3750px × 5000px
Photo credit: © MoleculeQuest / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: acid, amino, ankylosing, antigen, arthritis, atoms, biological, biotech, biotechnology, blood, cell, colitis, crohn´, diagnosis, disease, drug, epitope, exemptia, fab, health, hidradenitis, human, humira, idiopathic, igg, immune, immunoglobulin, immunotherapy, juvenile, medical, methotrexate, micro, molecule, peptide, polymer, polypeptide, protein, psoriasis, research, response, rheumatoid, small, spondylitis, structure, suppurativa, surface, system, tertiary, therapeutic, ulcerative, virus